ArticleJournal of experimental & clinical cancer research : CR2024

ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages.

Xin Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.